Barbieri R, Gambari R, Buzzoni D, Piva R, Orlando P, Mischiati C, del Senno L, Nastruzzi C, Giacomini P, Natali P G
Istituto di Chimica Biologica, Università di Ferrara, Roma, Italy.
Tumori. 1989 Aug 31;75(4):321-8. doi: 10.1177/030089168907500405.
The methylation pattern of the human HLA-DR alpha gene was analyzed in primary tumors and lymph node metastases isolated from patients with a variety of tumors, including thyroid, pancreas, breast and gastric carcinomas and melanomas. In normal tissues (including breast, muscle, brain, sperm, T-and B-lymphocytes) the HLA-DR alpha gene is hypermethylated at CCGG and GCGC sites. In all tissues studied, the only constantly unmethylated region was located in the 5' portion of the gene. Our results indicate that the HLA-DR alpha gene is hypomethylated in metastatic lymph nodes, as well as in the carcinomas and melanomas studied. These findings lend support to the hypothesis that DNA hypomethylation of the human HLA-DR alpha gene may represent a molecular marker of malignant tumors.
对从患有多种肿瘤(包括甲状腺癌、胰腺癌、乳腺癌、胃癌和黑色素瘤)的患者中分离出的原发性肿瘤和淋巴结转移灶,分析了人类HLA - DRα基因的甲基化模式。在正常组织(包括乳腺、肌肉、脑、精子、T淋巴细胞和B淋巴细胞)中,HLA - DRα基因在CCGG和GCGC位点高度甲基化。在所有研究的组织中,唯一持续未甲基化的区域位于该基因的5'端部分。我们的结果表明,HLA - DRα基因在转移性淋巴结以及所研究的癌和黑色素瘤中是低甲基化的。这些发现支持了这样的假说,即人类HLA - DRα基因的DNA低甲基化可能代表恶性肿瘤的分子标志物。